Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Désiré Challuau"'
Autor:
Erika Velasquez, Ekaterina Savchenko, Sara Marmolejo-Martínez-Artesero, Désiré Challuau, Aline Aebi, Yuriy Pomeshchik, Nuno Jorge Lamas, Mauno Vihinen, Melinda Rezeli, Bernard Schneider, Cedric Raoul, Laurent Roybon
Publikováno v:
Neurobiology of Disease, Vol 201, Iss , Pp 106687- (2024)
Astrocytes play a crucial role in the onset and progression of amyotrophic lateral sclerosis (ALS), a fatal disorder marked by the degeneration of motor neurons (MNs) in the central nervous system. Although astrocytes in ALS are known to be toxic to
Externí odkaz:
https://doaj.org/article/96141882157d42c4b7a55ed53795b7d5
Autor:
Richard Younes, Youssef Issa, Nadia Jdaa, Batoul Chouaib, Véronique Brugioti, Désiré Challuau, Cédric Raoul, Frédérique Scamps, Frédéric Cuisinier, Cécile Hilaire
Publikováno v:
Biomedicines, Vol 11, Iss 8, p 2152 (2023)
Amyotrophic lateral sclerosis (ALS) is a fatal and incurable paralytic disorder caused by the progressive death of upper and lower motoneurons. Although numerous strategies have been developed to slow disease progression and improve life quality, to
Externí odkaz:
https://doaj.org/article/bd5e80d3b152444d8948c698babc4e16
Autor:
Salim Benlefki, Richard Younes, Désiré Challuau, Nathalie Bernard-Marissal, Cécile Hilaire, Frédérique Scamps, Melissa Bowerman, Rashmi Kothary, Bernard L Schneider, Cédric Raoul
Amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA) are the most common motoneuron diseases affecting adults and infants, respectively. ALS and SMA are both characterized by the selective degeneration of motoneurons. Although differ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08a3d51ee78bbb5ca9d71929e14a2623
https://doi.org/10.1101/2022.05.12.491475
https://doi.org/10.1101/2022.05.12.491475
Autor:
Désiré Challuau, Benoît Hosten, Michel Perricaudet, Céline Bouquet, Sylvie Marion, Sophie Gil, Robert Farinotti, Mario Di Palma, Laurence Bonhomme-Faivre
Publikováno v:
Anti-Cancer Drugs
Anti-Cancer Drugs, Lippincott, Williams & Wilkins, 2006, 17 (2), pp.195-9
Anti-Cancer Drugs, Lippincott, Williams & Wilkins, 2006, 17 (2), pp.195-9
International audience; The aim of the present study was to examine modifications of anti-tumor activity and toxicity of paclitaxel (PLX) when given p.o. after recombinant interleukin-2 (rIL-2) to Lewis lung carcinoma-bearing mice. PLX was given oral